Growth Metrics

CureVac N.V (CVAC) Long-Term Deferred Tax: 2020-2025

Historic Long-Term Deferred Tax for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $4.7 million.

  • CureVac N.V's Long-Term Deferred Tax rose 728.43% to $4.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.7 million, marking a year-over-year increase of 728.43%. This contributed to the annual value of $5.4 million for FY2024, which is 34.97% down from last year.
  • Per CureVac N.V's latest filing, its Long-Term Deferred Tax stood at $4.7 million for Q2 2025, which was down 25.44% from $6.2 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Long-Term Deferred Tax registered a high of $8.4 million during Q4 2023, and its lowest value of $267,966 during Q3 2024.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $1.4 million (2023), whereas its average is $3.0 million.
  • Per our database at Business Quant, CureVac N.V's Long-Term Deferred Tax crashed by 81.04% in 2024 and then soared by 1,003.56% in 2025.
  • Quarterly analysis of 5 years shows CureVac N.V's Long-Term Deferred Tax stood at $3.3 million in 2021, then surged by 148.41% to $8.1 million in 2022, then rose by 2.92% to $8.4 million in 2023, then tumbled by 34.97% to $5.4 million in 2024, then surged by 728.43% to $4.7 million in 2025.
  • Its Long-Term Deferred Tax stands at $4.7 million for Q2 2025, versus $6.2 million for Q1 2025 and $5.4 million for Q4 2024.